FY25 revenue consensus $2.79B.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBIX:
- Neurocrine price target raised to $184 from $182 at BofA
- Neurocrine price target raised to $185 from $170 at Morgan Stanley
- NBIX Upcoming Earnings Report: What to Expect?
- Neurocrine price target raised to $176 from $162 at UBS
- Neurocrine initiates Phase 3 registrational program for osavampator in MDD